首頁 > 市場調查報告書 > 醫療設備

病患監測

市場調查報告書

商品編碼

1542902

全球骨密度儀設備市場 - 2024-2031

Global Bone Densitometer Devices Market - 2024-2031

出版日期: 2024年08月26日 | 出版商:

DataM Intelligence | 英文 182 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

市場規模

全球骨密度儀市場在2023年達到3.1136億美元，預計到2031年將達到4.5273億美元，在2024-2031年預測期間複合年成長率為4.8%。

骨密度計是一種醫學影像設備，用於測量骨密度，以確定患者是否患有骨質疏鬆症，骨質疏鬆症的症狀是骨骼更脆弱，更容易骨折。密度計利用 X 光來估計一段骨頭中填充了多少克鈣和其他骨礦物質。

骨密度儀市場趨勢

骨質疏鬆症盛行率不斷上升

骨密度儀設備的全球市場成長預計將受到預測期內骨質疏鬆症盛行率不斷上升的推動。據國際骨質疏鬆基金會稱，預計到2050 年，男性髖部骨折的發生率將增加300% 以上，女性髖部骨折的發生率將增加240%。疾病的盛行率增加，凸顯了進行骨骼檢查的必要性。

根據 IOF（國際骨質疏鬆症基金會）的數據，全球每年有超過 890 萬例骨折是由骨質疏鬆症引起的，每 3 秒就會發生一次骨質疏鬆性破裂。此外，美國國立衛生研究院估計，有超過 2 億人患有骨質疏鬆症。此外，國際骨質疏鬆基金會的統計數據表明，50歲以上的女性中有三分之一和男性中有五分之一預計在一生中會遭遇骨質疏鬆性骨折。

此外，老年人口的成長和研究活動的增加是預測期內推動全球市場的其他因素。

骨密度儀成本高

然而，骨密度計的高成本預計將阻礙預測期內全球骨密度計市場的成長。例如，早期的 GE Prodigy 系列、GE DPX 系列和 Hologic Discovery 系列的價格約為 16,000 美元至 21,000 美元。後來的GE Prodigy系列、後來的Hologic Discovery系列和早期的Hologic Horizon系列售價為22,000 - 28,000美元，而最新的GE Prodigy系列、GE iDXA和Hologic Horizons A和W售價在30,000 - 45,000美元之間，從而減緩了全球骨密度儀市場的發展預測期內的成長。

骨密度儀市場細分

全球骨密度計設備市場根據技術、應用、最終用戶和地區進行細分。

雙能量 X光吸收測定法 (DEXA) 技術領域預計將主導市場

在預測期內，全球骨密度儀市場預計將由雙能量X光骨密度儀（DEXA）主導。 DEXA 因其許多優點而優於其他骨密度計設備技術。透過讓骨骼發出兩種不同能量水平的 X光，DEXA 可以測量骨骼中鈣和礦物質的比例。其優點包括輻射劑量低、準確且簡單。

此外，與電腦斷層掃描和磁振造影相比，DXA 可以提供非常準確的脂肪量 (FM) 和瘦體重 (LM) 值讀數。根據《Bone Journal》報導，DEXA 是估計骨礦物質密度 (BMD)、診斷骨質疏鬆症以及監測 BMD 隨時間變化以確定骨折風險的黃金標準。超音波檢查的使用頻率低於 DEXA，因為沒有使用超音波測量來診斷骨質疏鬆症或預測骨折風險的精確指南。因此，根據上述資料，預計DEXA將在整個預測期內繼續主導全球骨密度計設備市場。

骨密度儀市場地域佔有率

北美可望主導全球市場

預計在整個預測期內，北美將佔據全球骨密度計市場的最大佔有率。這是由於該地區停經後女性人口不斷增加。例如，根據北美更年期協會的數據，每年有超過 200 萬名美國女性進入更年期，預計到 2026 年，近四分之一的加拿大居民將是 50 歲以上的女性。 , Inc.、Tecnicare Healthcare Co、Hologic, Inc. 和GE Healthcare 等公司在骨密度儀市場上佔有相當大的佔有率，確保了該地區的主導地位。

這些主要參與者透過產品發布、合作夥伴關係、市場核准、收購、合作等多樣化的市場策略，佔領了主要市場佔有率。深入推動了該地區在全球骨密度計市場的主導地位。例如，UnitedHealthcare 於 2022 年 9 月批准了骨量測量 (BMM) 的醫療保險承保，骨量測量是一種放射學、放射性同位素或其他程序。

COVID-19 影響分析

COVID-19 大流行對骨密度儀市場產生了重大影響，因為根據《歐洲醫學和藥理學科學評論》，繼發性骨質疏鬆症可能是 COVID-19 的急性後後果。因此，需要在追蹤時密切觀察COVID-19住院後患者的骨骼健康狀況，以利於骨質疏鬆併發症的預防和早期治療。

此外，印第安納大學研究人員表示，根據長期研究，即使是輕微的 COVID-19 感染也會導致骨密度快速且顯著的下降。因此，監測 COVID-19 感染患者骨密度的需求增加，增加了對骨密度計設備的需求，並對全球骨密度計設備市場的成長產生正面影響。

主要進展

2021 年5 月，在佛羅裡達州骨科學會年度科學會議上，Echolight 推出了射頻回波多光譜測量(REMS)，這是第一個以攜帶式骨密度計形式提供的無輻射技術，可以在更高的溫度下安全地掃描基本的骨骼健康指標。

2021 年 5 月，臨床診斷領導者 Beckman Coulter 推出了 DxA 5000 Fit，這是一種工作流程自動化解決方案，專為適合每天執行少於 5,000 項測試的中型實驗室而開發。

骨密度儀市場關鍵參與者

該市場的主要全球參與者包括 GE Healthcare、BeamMed、Diagnostic Medical System、Eco light Healthcare、Hologic Inc.、Medonica、Osteosys、Swissray、OSI Systems, Inc. 和 Tecnicare Healthcare Co。

為什麼購買報告？

根據技術、應用、最終用戶和地區可視化全球骨密度計設備市場細分，並了解關鍵商業資產和參與者。

透過分析趨勢和共同開發來識別商業機會。

Excel資料表包含所有細分市場層級的骨密度計設備的大量資料點。

PDF 報告由詳盡的質性訪談和深入研究後的綜合分析組成。

產品映射以 Excel 形式提供，包含所有主要參與者的關鍵產品。

全球骨密度儀設備市場報告將提供約 61 個表格、58 個圖表和 182 頁。

2024 年目標受眾

製造商/買家

產業投資者/投資銀行家

研究專業人員

新興公司

A bone densitometer is a medical imaging device employed to measure bone density to determine if the patient has osteoporosis, a disorder indicated by more fragile bones that are more likely to break. The densitometer utilizes X-rays to estimate how many grams of calcium and other bone minerals are filled into a segment of bone.

Bone Densitometer Market Trends

Growing Prevalence of Osteoporosis

The global market growth for Bone Densitometer Devices is expected to be driven by the growing prevalence of osteoporosis during the forecast period. According to the International Osteoporosis Foundation, there is an anticipated over 300% gain in hip fractures among males and a 240% boost among females by 2050. This highlights the necessity for bone examination, pushed by the increased preponderance of osteoporosis and corresponding disorders like osteopenia, osteomalacia, and osteoporotic fractures.

Globally, over 8.9 million fractures annually are rendered by osteoporosis, resulting in an osteoporotic rupture every 3 seconds, according to the IOF (International Osteoporosis Foundation). Moreover, the NIH estimated that over 200 million individuals suffer from osteoporosis. Moreover, statistics from the International Osteoporosis Foundation indicate that 1 in 3 females over the age of 50 years and 1 in 5 males are expected to encounter osteoporotic fractures in their lifetime.

Additionally, the growing geriatric population and increased research activities are among the additional factors boosting the global market during the forecast period.

High Cost of Bone Densitometer

However, the high cost of the bone densitometer is expected to hamper the global bone densitometer market growth during the forecast period. For instance, the early GE Prodigy Series, GE DPX series, and Hologic Discovery series cost roughly $16,000 to $21,000. The later GE Prodigy series, later Hologic Discovery series, and the early Hologic Horizon series cost $22,000 - $28,000 while the latest GE Prodigy series, GE iDXA, and Hologic Horizons A and W cost between $30,000 - $45,000 thus, slowing the global bone densitometer market growth during the forecast period.

Bone Densitometer Market Segmentation

The global bone densitometer devices market is segmented based on technology, application, end user and region.

Dual-Energy X-ray Absorptiometry (DEXA) Technology Segment is Expected to Dominate Market

During the forecast period, the global bone densitometer market is expected to be dominated by dual-energy X-ray absorptiometry (DEXA). DEXA is preferred over other bone densitometer device techniques because of its many advantages. By passing X-rays with two different energy levels from the bone, DEXA measures the proportion of calcium and minerals in the bones. Its advantages include low radiation dose, accuracy, and simplicity.

In addition, compared with computed tomography and magnetic resonance imaging, DXA provides very accurate readings of fat mass (FM) and lean mass (LM) values. According to Bone Journal, DEXA is the gold standard for estimating bone mineral density (BMD), diagnosing osteoporosis, and monitoring changes in BMD over time to determine fracture risk. Ultrasound is less frequently used than DEXA because there are no precise guidelines for using ultrasound measurement to diagnose osteoporosis or predict fracture risk. Therefore, based on the above data, it is expected that DEXA will continue to dominate the global bone densitometer device market throughout the forecast period.

Bone Densitometer Market Geographical Share

North America is Expected to Dominate the Global Market

North America is expected to hold the largest share of the global bone densitometer market throughout the forecast period. This is owing to the growing post-menopausal female population in the region. For instance, according to the North American Menopause Society, over 2 million US females attain menopause annually, and it is estimated that by 2026, nearly one-quarter of the Canadian residents will be females over 50. Moreover, the presence of major market players such as OSI Systems, Inc., Tecnicare Healthcare Co., Hologic, Inc., and GE Healthcare, who hold a substantial share of the bone densitometer market, ensures the dominance of this region.

These key players have captured a major share of the market via diverse market strategies such as product launches, partnerships, market approvals, acquisitions, collaborations, etc. Additionally, the new policy guidelines of different healthcare and insurance companies in the United States for the reimbursement of bone density studies are contributing to the dominance of this region over the global bone densitometer market. For example, UnitedHealthcare, in September 2022, approved Medicare coverage for Bone Mass Measurement (BMM), which is a radiologic, radioisotope, or other procedure.

COVID-19 Impact Analysis

The COVID-19 pandemic has significantly influenced the bone densitometer market since, according to the European Review for Medical and Pharmacological Sciences, there is the possibility of Secondary osteoporosis as a post-acute consequence of COVID-19. Thus, the bone health situation of patients outliving COVID-19 hospitalization needs to be observed closely at follow-up visits, facilitating the prevention and early treatment of osteoporosis complications.

Furthermore, according to Indiana University researchers, even a mild infection of COVID-19 can cause rapid and significant bone density loss, according to long-term research. Therefore, increasing the need for monitoring the bone density of the patients who suffered COVID-19 infection, increasing the demand for bone densitometer devices and positively impacting the global bone densitometer device market growth.

Key Developments

In May 2021, At the Florida Orthopedic Society Annual Scientific Meeting, Echolight introduced Radiofrequency Echographic Multi Spectrometry (REMS), the first radiation-free technology provided in the shape of a portable bone densitometer that can safely scan essential bone health indicators at a more elevated frequency than different testing methods.

In May 2021, Beckman Coulter, a clinical diagnostics leader, launched the DxA 5000 Fit, a workflow-automation solution developed to fit into medium-sized labs that execute less than 5,000 tests per day.

Bone Densitometer Market Key Players

The major global players in the market include GE Healthcare, BeamMed, Diagnostic Medical System, Eco light Healthcare, Hologic Inc., Medonica, Osteosys, Swissray, OSI Systems, Inc. and Tecnicare Healthcare Co.

Why Purchase the Report?

To visualize the global bone densitometer devices market segmentation based on technology, application, end user and region as well as understand key commercial assets and players.

Identify commercial opportunities by analyzing trends and co-development.

Excel data sheet with numerous data points of bone densitometer devices market-level with all segments.

PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.

Product mapping available as excel consisting of key product of all the major players.

The global bone densitometer devices market report would provide approximately 61 tables, 58 figures and 182 pages.

Target Audience 2024

Manufacturers/ Buyers

Industry Investors/Investment Bankers

Research Professionals

Emerging Companies

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Technology
3.2. Snippet by Application
3.3. Snippet by End User
3.4. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Growing Prevalence of Osteoporosis
- 4.1.2. Restraints
  - 4.1.2.1. High Cost of Bone Densitometer
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Pricing Analysis
5.3. Regulatory Analysis
5.4. Patent Analysis
5.5. Technology and Trend Analysis
5.6. Unmet Need
5.7. SWOT Analysis
5.8. DMI Opinion

6. COVID-19 Analysis

6.1. Analysis of COVID-19
- 6.1.1. Scenario Before COVID
- 6.1.2. Scenario During COVID
- 6.1.3. Scenario Post COVID
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion

7. By Technology

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 7.1.2. Market Attractiveness Index, By Technology
7.2. Dual Energy X-Ray Absorptiometry (DEXA)*
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Quantitative Computed Tomography
7.4. Quantitative Ultrasound
7.5. Single Energy X-Ray Absorptiometry
7.6. Others

8. By Application

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 8.1.2. Market Attractiveness Index, By Application
8.2. Peripheral Bone Densitometry*
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Axial Bone Densitometry

9. By End User

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 9.1.2. Market Attractiveness Index, By End User
9.2. Hospitals*
- 9.2.1. Introduction
- 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Specialty Clinics
9.4. Others

10. By Region

10.1. Introduction
- 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 10.1.2. Market Attractiveness Index, By Region
10.2. North America
- 10.2.1. Introduction
- 10.2.2. Key Region-Specific Dynamics
- 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.2.6.1. U.S.
  - 10.2.6.2. Canada
  - 10.2.6.3. Mexico
10.3. Europe
- 10.3.1. Introduction
- 10.3.2. Key Region-Specific Dynamics
- 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.3.6.1. Germany
  - 10.3.6.2. UK
  - 10.3.6.3. France
  - 10.3.6.4. Italy
  - 10.3.6.5. Spain
  - 10.3.6.6. Rest of Europe
10.4. South America
- 10.4.1. Introduction
- 10.4.2. Key Region-Specific Dynamics
- 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.4.6.1. Brazil
  - 10.4.6.2. Argentina
  - 10.4.6.3. Rest of South America
10.5. Asia-Pacific
- 10.5.1. Introduction
- 10.5.2. Key Region-Specific Dynamics
- 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.5.6.1. China
  - 10.5.6.2. India
  - 10.5.6.3. Japan
  - 10.5.6.4. Australia
  - 10.5.6.5. Rest of Asia-Pacific
10.6. Middle East and Africa
- 10.6.1. Introduction
- 10.6.2. Key Region-Specific Dynamics
- 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

11. Competitive Landscape

11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis

12. Company Profiles

12.1. GE Healthcare*
- 12.1.1. Company Overview
- 12.1.2. Product Portfolio and Description
- 12.1.3. Financial Overview
- 12.1.4. Key Developments
12.2. BeamMed
12.3. Diagnostic Medical System, Inc.
12.4. ECO LIGHT HEALTHCARE
12.5. Hologic Inc.
12.6. Medonica
12.7. Osteosys
12.8. Swissray
12.9. OSI Systems, Inc.
12.10. Tecnicare Healthcare Co.

LIST NOT EXHAUSTIVE